Search Results for " Daridorexant "
Daridorexant Related Products
Daridorexant is a dual orexin receptor antagonist used to treat insomnia in adults.and is the first orexin receptor antagonist to become available in European Union The medication is a schedule IV controlled substance in the United States and may have a modest potential for misuse.
SynZeal is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Daridorexant, pharmacopeial and non-pharmacopeial Daridorexant impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Daridorexant impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.
Daridorexant-related products are thoroughly characterized. Daridorexant products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.